Liver regeneration

Last updated April 07, 2024

Liver regeneration is the process by which the liver is able to replace damaged or lost liver tissue. The liver is the only visceral organ with the capacity to regenerate.^[1]^[2] The liver can regenerate after partial hepatectomy or injury due to hepatotoxic agents such as certain medications, toxins, or chemicals.^[3] Only 51% of the original liver mass is required for the organ to regenerate back to full size.^[2]^[4] The phenomenon of liver regeneration is seen in all vertebrates, from humans to fish.^[5] The liver manages to restore any lost mass and adjust its size to that of the organism, while at the same time providing full support for body homeostasis during the entire regenerative process.^[5] The process of regeneration in mammals is mainly compensatory growth or hyperplasia because while the lost mass of the liver is replaced, it does not regain its original shape.^[6] During compensatory hyperplasia, the remaining liver tissue becomes larger so that the organ can continue to function. In lower species such as fish, the liver can regain both its original size and mass.^[7]

Mechanism

The liver is able to regenerate after a partial hepatectomy and damage by hepatotoxins or infection.

Liver regeneration following partial hepatectomy is a very complex and well-coordinated phenomenon.^[5] It involves all types of mature liver cells.^[5] The process includes growth factors involved in signaling cascades, cytokines, matrix remodeling, and several feedback reactions of stimulation and inhibition of growth related signals.^[5]

Liver regeneration following partial hepatectomy occurs in three phases including (a) initiation or priming phase, (b) proliferation phase, and (c) termination phase.^[8] Priming phase occurs within 5 hours of hepatectomy and involves activation and over expression of multiple specific genes to prepare the liver cells (hepatocytes) for replication. The regulatory mechanisms prepare hepatocytes to enter the cell cycle. The proliferation phase involves activation of various growth factors, including two factors that play a major role in liver regeneration, EGFR (epidermal growth factor receptor) and c-Met. During this phase, hepatocytes undergo a series of cell division cycles and expansion.^[8] Termination phase is coordinated by TGF-β (transforming growth factor beta) that is responsible for stopping the regenerative process and preventing liver overgrowth.^[8]^[9]

During the first 5 minutes following partial hepatectomy, hemodynamic changes in the liver elevate portal blood pressure, causing turbulent blood flow and mechanical stress on the endothelial cells.^[8] The mechanical stress causes epithelial cells to express an increased activity of urokinase plasminogen activator (uPA).^[8] Increased uPA activity initiates conversion of plasminogen into plasmin, which breaks down fibrinogen into fibrinogen degradation products (FDPs).^[8] Plasmin also causes transformation of pro-matrix metalloproteinases (pro-MMPs) into active matrix metalloproteinases (MMPs).^[8] Both, plasmin and MMPs, are responsible for matrix remodeling and turnover of many proteins in the extracellular matrix (ECM).^[8] ECM remodeling initiates signaling impulses through integrin and leads to the release of local growth factors.^[8] The cascade starts with the uPA coordinated activation of an inactive hepatic growth factor (HGF) that is attached to ECM.^[8] Within 30 minutes to 1 hour after partial hepatectomy, active HGF is excreted locally and systematically and it activates hepatic growth factor receptor (HGFR or cMet).^[8] At the same time, epidermal growth factor (EGF), produced by duodenal Brunner's glands and released to the portal circulation, stimulates epidermal growth factor receptor (EGFR).^[8]

The priming phase of liver regeneration following partial hepatectomy occurs outside of hepatocytes in the ECM and it prepares the liver for regeneration and hepatocyte proliferation.^[5] During proliferation phase of liver regeneration, there is a communication between β-catenin, the Notch signaling pathway, and two growth factors, EGF and HGF.^[9] β-catenin plays a supportive role in liver regeneration.^[8] Wnt/β-catenin signaling is an important coordinator of liver regeneration that starts to operate within 1–3 hours after partial hepatectomy.^[8] β-catenin exhibits rapid nuclear translocation in partial hepatectomy model of liver regeneration in rats.^[10] Notch pathway is one of the earliest pathways that is turned on within 15–30 min after partial hepatectomy.^[8] Notch signaling pathway is generally dependent on two main proteins known as NOTCH-1 receptor and JAGGED-1 (NOTCH-1 ligand), which are markedly up regulated 1–5 days following partial hepatectomy.^[8] There is a communication between β-catenin (inside the hepatocyte) and the growth factors EGFR and HGFR or c-Met (outside the hepatocyte).^[9] The presence of these two proteins increases the regenerative response because the HGF and EGFR act as direct mitogens inducing a strong mitogenic response from proliferating hepatocytes.^[5]

After the liver regeneration process is completed, TGF-β puts an end to the proliferation phase by inducing apoptosis.^[9] TGF-β is the most important anti-proliferative factor that stops the process of liver regeneration.^[8] TGF-β inhibits the proliferation of hepatocytes by repressing HGF and urokinase activity.^[5] This process is able to bring the hepatocytes back into their quiescent state.^[5]

Sometimes, hepatocytes do not have the ability to proliferate and an alternative form of regeneration may take place to rebuild the liver.^[5] When hepatocytes or biliary cells are unable or blocked from regeneration, these cell types can function as facultative stem cells for each other.^[5]^[11] When hepatocytes cannot proliferate, biliary epithelial cells are capable of turning into hepatocytes.^[5] The reverse can also occur, with hepatocytes turning into biliary cells when biliary cells cannot proliferate.^[5] Facultative stem cells have a day-to-day function in the body, but can also function as stem cells for other types of cells when those cells are damaged.^[11] These two types of cells can repair liver tissue even when the normal mechanism of liver regeneration fails.^[11]

Liver Damage

In otherwise healthy patients, the liver is capable of regenerating up to half its mass in 30 days.^[12] If patients have underlying liver problems, regeneration may stop before the liver is completely regenerated or the liver may begin to scar.^[12] Scarring of the liver is very dangerous and can lead to further serious complications and chronic liver disease.^[12] Complications increase when the initial cause of the liver damage is still present.^[12] Liver damage can be caused by viruses, alcohol, medications, and other hepatotoxins.^[12] Acetaminophen, found in many prescription and over-the-counter medications, is the most common drug that can cause liver damage if taken in a high dose or in conjunction with alcohol.^[12] Many liver transplant patients require the transplant because of acetaminophen overdose.^[12]

Liver Disease

There are multiple causes of liver diseases, including infection, autoimmune and genetic diseases, cancers, alcohol abuse, fat accumulation in the liver (non alcoholic fatty liver disease), prescription drugs, and herbal compounds.^[13]^[14]^[15] Risk factors that increase the probability liver diseases are developed include obesity, type 2 diabetes, tattoos or body piercings, IV drug use, exposure to another person's bodily fluids, unprotected sexual intercourse, and exposure to chemicals and toxins. Examples of different liver diseases include: viral hepatitis A, B, and C, autoimmune diseases such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), benign tumors (adenoma, hemangioma), malignancies (liver cancer, bile duct cancer), genetic disorders (hemochromatosis, Wilson's disease, hyperoxaluria).

Function

The liver is a critical organ that is responsible for many different homeostatic functions that help support metabolism, immunity, digestion, detoxification, and carbohydrates and vitamin storage.^[16]^[17] The detoxification function of the liver exposes the organ to many chemicals, which can induce hepatocyte injury and death. The liver can rapidly regenerate its damaged tissue, preventing liver failure. However, the speed of liver regeneration depends on whether interleukin 6 (IL 6) is overexpressed.^[18] IL 6 is a critical component in priming the hepatocytes for proliferation and it has the crucial role in initiation of the acute phase response in hepatocytes.^[5] IL 6 is responsible for a rapid increase in production by hepatocytes of many proteins, which assist in controlling acute or chronic inflammation.^[5] IL 6 is produced by hepatic macrophages, however, previous studies have shown that it is produced by hepatoma cell lines, suggesting that it may also be produced by hepatocytes themselves.^[5] IL 6 binds to its receptor, a complex of gp80 and gp130 subunits, on hepatocytes.^[5] Activation of gp130 subunit results in tyrosine kinase activity that phosphorylates a signal transducer and activator of transcription (STAT 3) and an extracellular signal-regulated protein kinase 1 and 2 (ERK1/2), causing an expression of multiple target genes important for hepatocyte proliferation such as Cyclin D1.^[5] It was reported that mice deficient in IL 6 have deficient liver regeneration, however, other studies have shown that liver regeneration in these mice is essentially normal, even though there is decreased activation of STAT 3.^[5] Mice over-expressing both IL 6 and its soluble receptor have areas of periportal hepatocyte hyperplasia.^[5] IL 6 is not a direct mitogen for hepatocytes.^[5] IL 6 is probably a factor contributing to optimizing processes of the early stage of liver regeneration, but it should not be viewed as the initiator of the process.^[5]

Diagnosis

Detecting the cause and the degree of liver damage is critical to treating liver diseases. Part of the diagnostic process is obtaining the history of drug and alcohol abuse, past viral infections, or any genetic conditions that may run in the family members and can contribute to the liver damage. Other parts of the diagnostic process include blood testing, liver imaging, and a tissue sampling or liver biopsy.^[19] Blood tests provide information about the liver function and viral or genetic etiology of liver diseases by checking liver enzymes, viral antigens and antibodies, or genetic testing. Imaging studies reveal the physical condition of the liver and they include ultrasounds, CT scans, and MRIs. Finally, a tissue sample of the liver can be obtained by conducting a liver biopsy. The sampled liver tissue is then studied under a microscope to detect the cause and the degree of liver damage.

Treatment

The treatment of liver diseases will vary depending on the etiology and the degree of liver damage. Treatment for some of the liver diseases may begin with eliminating hepatotoxins such alcohol or acetaminophen by simple lifestyle modifications; cutting back on alcohol consumption, acetaminophen intake, or weight loss could be the initial step of the treatment process. More complicated liver diseases including liver cancer may require more advanced or invasive procedures such as ablation or embolization. The most complicated form of the treatment of end stage liver diseases is the liver transplant.

Related Research Articles

A growth factor is a naturally occurring substance capable of stimulating cell proliferation, wound healing, and occasionally cellular differentiation. Usually it is a secreted protein or a steroid hormone. Growth factors are important for regulating a variety of cellular processes.

Alcoholic liver disease (ALD), also called alcohol-related liver disease (ARLD), is a term that encompasses the liver manifestations of alcohol overconsumption, including fatty liver, alcoholic hepatitis, and chronic hepatitis with liver fibrosis or cirrhosis.

The G₀ phase describes a cellular state outside of the replicative cell cycle. Classically, cells were thought to enter G₀ primarily due to environmental factors, like nutrient deprivation, that limited the resources necessary for proliferation. Thus it was thought of as a resting phase. G₀ is now known to take different forms and occur for multiple reasons. For example, most adult neuronal cells, among the most metabolically active cells in the body, are fully differentiated and reside in a terminal G₀ phase. Neurons reside in this state, not because of stochastic or limited nutrient supply, but as a part of their developmental program.

Alcoholic hepatitis is hepatitis due to excessive intake of alcohol. Patients typically have a history of at least 10 years of heavy alcohol intake, typically 8–10 drinks per day. It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to the progression of fibrosis, leading to cirrhosis. Symptoms may present acutely after a large amount of alcoholic intake in a short time period, or after years of excess alcohol intake. Signs and symptoms of alcoholic hepatitis include jaundice, ascites, fatigue and hepatic encephalopathy. Mild cases are self-limiting, but severe cases have a high risk of death. Severe cases may be treated with glucocorticoids. The condition often comes on suddenly and may progress in severity very rapidly.

Autoimmune hepatitis, formerly known as lupoid hepatitis, plasma cell hepatitis, or autoimmune chronic active hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells, causing the liver to be inflamed. Common initial symptoms may include fatigue, nausea, muscle aches, or weight loss or signs of acute liver inflammation including fever, jaundice, and right upper quadrant abdominal pain. Individuals with autoimmune hepatitis often have no initial symptoms and the disease may be detected by abnormal liver function tests and increased protein levels during routine bloodwork or the observation of an abnormal-looking liver during abdominal surgery.

<span class="mw-page-title-main">Biliary atresia</span> Medical condition

Biliary atresia, also known as extrahepatic ductopenia and progressive obliterative cholangiopathy, is a childhood disease of the liver in which one or more bile ducts are abnormally narrow, blocked, or absent. It can be congenital or acquired. It has an incidence of one in 10,000–15,000 live births in the United States, and a prevalence of one in 16,700 in the British Isles. Biliary atresia is most common in East Asia, with a frequency of one in 5,000.

Myosatellite cells, also known as satellite cells, muscle stem cells or MuSCs, are small multipotent cells with very little cytoplasm found in mature muscle. Satellite cells are precursors to skeletal muscle cells, able to give rise to satellite cells or differentiated skeletal muscle cells. They have the potential to provide additional myonuclei to their parent muscle fiber, or return to a quiescent state. More specifically, upon activation, satellite cells can re-enter the cell cycle to proliferate and differentiate into myoblasts.

Amphiregulin, also known as AREG, is a protein synthesized as a transmembrane glycoprotein with 252 aminoacids and it is encoded by the AREG gene. in humans.

Cholestasis is a condition where the flow of bile from the liver to the duodenum is impaired. The two basic distinctions are:

Hepatocyte growth factor receptor is a protein that in humans is encoded by the MET gene. The protein possesses tyrosine kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor.

Hepatocyte growth factor (HGF) or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.

Matrilysin also known as matrix metalloproteinase-7 (MMP-7), pump-1 protease (PUMP-1), or uterine metalloproteinase is an enzyme in humans that is encoded by the MMP7 gene. The enzyme has also been known as matrin, putative metalloproteinase-1, matrix metalloproteinase pump 1, PUMP-1 proteinase, PUMP, metalloproteinase pump-1, putative metalloproteinase, MMP). Human MMP-7 has a molecular weight around 30 kDa.

Kunitz-type protease inhibitor 1 is an enzyme that in humans is encoded by the SPINT1 gene.

Hepatocyte growth factor activator is a protein that in humans is encoded by the HGFAC gene.

The liver is a major metabolic organ only found in vertebrate animals, which performs many essential biological functions such as detoxification of the organism, and the synthesis of proteins and biochemicals necessary for digestion and growth. In humans, it is located in the right upper quadrant of the abdomen, below the diaphragm and mostly shielded by the lower right rib cage. Its other metabolic roles include carbohydrate metabolism, the production of hormones, conversion and storage of nutrients such as glucose and glycogen, and the decomposition of red blood cells.

Cirrhosis, also known as liver cirrhosis or hepatic cirrhosis, and end-stage liver disease, is the impaired liver function caused by the formation of scar tissue known as fibrosis due to damage caused by liver disease. Damage to the liver leads to repair of liver tissue and subsequent formation of scar tissue. Over time, scar tissue can replace normal functioning tissue, leading to the impaired liver function of cirrhosis. The disease typically develops slowly over months or years. Early symptoms may include tiredness, weakness, loss of appetite, unexplained weight loss, nausea and vomiting, and discomfort in the right upper quadrant of the abdomen. As the disease worsens, symptoms may include itchiness, swelling in the lower legs, fluid build-up in the abdomen, jaundice, bruising easily, and the development of spider-like blood vessels in the skin. The fluid build-up in the abdomen may develop into spontaneous infections. More serious complications include hepatic encephalopathy, bleeding from dilated veins in the esophagus, stomach, or intestines, and liver cancer.Stages of cirrhosis include compensated cirrhosis and decompensated cirrhosis.

Human HGF plasmid DNA therapy of cardiomyocytes is being examined as a potential treatment for coronary artery disease, as well as treatment for the damage that occurs to the heart after MI. After MI, the myocardium suffers from reperfusion injury which leads to death of cardiomyocytes and detrimental remodelling of the heart, consequently reducing proper cardiac function. Transfection of cardiac myocytes with human HGF reduces ischemic reperfusion injury after MI. The benefits of HGF therapy include preventing improper remodelling of the heart and ameliorating heart dysfunction post-MI.

George K. Michalopoulos is a Greek-American pathologist and academic. He served as Maud L. Menten Professor of Experimental Pathology and Chair of the Department of Pathology at the University of Pittsburgh and UPMC from 1991 to 2023.

Hyperbilirubinemia is a clinical condition describing an elevation of blood bilirubin level due to the inability to properly metabolise or excrete bilirubin, a product of erythrocytes breakdown. In severe cases, it is manifested as jaundice, the yellowing of tissues like skin and the sclera when excess bilirubin deposits in them. The US records 52,500 jaundice patients annually. By definition, bilirubin concentration of greater than 3 mg/ml is considered hyperbilirubinemia, following which jaundice progressively develops and becomes apparent when plasma levels reach 20 mg/ml. Rather than a disease itself, hyperbilirubinemia is indicative of multifactorial underlying disorders that trace back to deviations from regular bilirubin metabolism. Diagnosis of hyperbilirubinemia depends on physical examination, urinalysis, serum tests, medical history and imaging to identify the cause. Genetic diseases, alcohol, pregnancy and hepatitis viruses affect the likelihood of hyperbilirubinemia. Causes of hyperbilirubinemia mainly arise from the liver. These include haemolytic anaemias, enzymatic disorders, liver damage and gallstones. Hyperbilirubinemia itself is often benign. Only in extreme cases does kernicterus, a type of brain injury, occur. Therapy for adult hyperbilirubinemia targets the underlying diseases but patients with jaundice often have poor outcomes.

Immune system contribution to regeneration of tissues generally involves specific cellular components, transcription of a wide variety of genes, morphogenesis, epithelia renewal and proliferation of damaged cell types. However, current knowledge reveals more and more studies about immune system influence that cannot be omitted. As the immune system exhibits inhibitory or inflammatory functions during regeneration, the therapies are focused on either stopping these processes or control the immune cells setting in a regenerative way, suggesting that interplay between damaged tissue and immune system response must be well-balanced. Recent studies provide evidence that immune components are required not only after body injury but also in homeostasis or senescent cells replacement.

References

↑ Prakash, Y. S., ed. (2011-01-31). Comprehensive Physiology (1 ed.). Wiley. doi:10.1002/cphy.c120014. ISBN 978-0-470-65071-4.
1 2 Michalopoulos, George K.; DeFrances, Marie C. (1997-04-04). "Liver Regeneration". Science. 276 (5309): 60–66. doi:10.1126/science.276.5309.60. ISSN 0036-8075. PMID 9082986.
↑ Mehendale, Harihara M. (January 2005). "Tissue Repair: An Important Determinant of Final Outcome of Toxicant-Induced Injury". Toxicologic Pathology. 33 (1): 41–51. doi:10.1080/01926230590881808. ISSN 0192-6233. PMID 15805055.
↑ Fausto, Nelson; Campbell, Jean S.; Riehle, Kimberly J. (February 2006). "Liver Regeneration". Hepatology. 43: S45–S53. doi:10.1002/hep.20969. ISSN 0270-9139. PMID 16447274.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Michalopoulos, George K. (November 2007). "Liver regeneration". Journal of Cellular Physiology. 213 (2): 286–300. doi:10.1002/jcp.21172. ISSN 0021-9541. PMC 2701258 . PMID 17559071.
↑ Fausto, Nelson (January 2000). "Liver regeneration". Journal of Hepatology. 32 (1 Suppl): 19–31. doi:10.1016/s0168-8278(00)80412-2. ISSN 0168-8278. PMID 10728791.
↑ Chu, Jaime; Sadler, Kirsten C. (November 2009). "New school in liver development: Lessons from zebrafish". Hepatology. 50 (5): 1656–1663. doi:10.1002/hep.23157. PMC 3093159 . PMID 19693947.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Abu Rmilah, Anan; Zhou, Wei; Nelson, Erek; Lin, Li; Amiot, Bruce; Nyberg, Scott L. (May 2019). "Understanding the marvels behind liver regeneration". WIREs Developmental Biology. 8 (3): e340. doi:10.1002/wdev.340. ISSN 1759-7684. PMC 6457252 . PMID 30924280.
1 2 3 4 Tao, Yachao; Wang, Menglan; Chen, Enqiang; Tang, Hong (2017-08-30). "Liver Regeneration: Analysis of the Main Relevant Signaling Molecules". Mediators of Inflammation. 2017: e4256352. doi: 10.1155/2017/4256352 . ISSN 0962-9351. PMC 5602614 . PMID 28947857.
↑ Behari, Jaideep (December 2010). "The Wnt/β-catenin signaling pathway in liver biology and disease". Expert Review of Gastroenterology & Hepatology. 4 (6): 745–756. doi:10.1586/egh.10.74. ISSN 1747-4124. PMC 3298845 . PMID 21108594.
1 2 3 Yanger, Kilangsungla; Stanger, Ben Z. (March 2011). "Facultative stem cells in liver and pancreas: Fact and fancy". Developmental Dynamics. 240 (3): 521–529. doi:10.1002/dvdy.22561. ISSN 1058-8388. PMC 4667725 . PMID 21312313.
1 2 3 4 5 6 7 "Liver disease: Frequently asked questions". University of Iowa Hospitals & Clinics. 2018-11-01. Retrieved 2024-04-06.
↑ Scorza, Manuela; Elce, Ausilia; Zarrilli, Federica; Liguori, Renato; Amato, Felice; Castaldo, Giuseppe (2014). "Genetic Diseases That Predispose to Early Liver Cirrhosis". International Journal of Hepatology. 2014: 713754. doi: 10.1155/2014/713754 . ISSN 2090-3448. PMC 4123515 . PMID 25132997.
↑ David, Stefan; Hamilton, James P (2010-01-01). "Drug-induced Liver Injury". US Gastroenterology & Hepatology Review. 6: 73–80. ISSN 1758-3934. PMC 3160634 . PMID 21874146.
↑ Nunes, David Ricardo da Conceição Marçal Alves; Monteiro, Cristina Sofia de Jesus; dos Santos, Jorge Luiz (2022-01-31). "Herb-Induced Liver Injury—A Challenging Diagnosis". Healthcare. 10 (2): 278. doi: 10.3390/healthcare10020278 . ISSN 2227-9032. PMC 8872293 . PMID 35206892.
↑ Tanaka, Minoru; Miyajima, Atsushi (2016-10-18). "Liver regeneration and fibrosis after inflammation". Inflammation and Regeneration. 36 (1): 19. doi: 10.1186/s41232-016-0025-2 . ISSN 1880-8190. PMC 5725806 . PMID 29259692.
↑ Kalra, Arjun; Yetiskul, Ekrem; Wehrle, Chase J.; Tuma, Faiz (2024), "Physiology, Liver", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 30571059 , retrieved 2024-04-06
↑ Tachibana, Shingo; Zhang, Xiuying; Ito, Kazushige; Ota, Yoshihiro; Cameron, Andrew M.; Williams, George Melville; Sun, Zhaoli (2014-02-03). "Interleukin-6 is required for cell cycle arrest and activation of DNA repair enzymes after partial hepatectomy in mice". Cell & Bioscience. 4 (1): 6. doi: 10.1186/2045-3701-4-6 . ISSN 2045-3701. PMC 3922598 . PMID 24484634.
↑ Lala, Vasimahmed; Zubair, Muhammad; Minter, David A. (2024), "Liver Function Tests", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 29494096 , retrieved 2024-04-06